Literature DB >> 15771235

Estimation of transdermal permeation parameters in non-stationary diffusion experiments. Application to pre-treatment studies with terpenes.

A Boix1, C Peraire, R Obach, J Domenech.   

Abstract

PURPOSE: To estimate the applicability of transdermal drug permeation parameters in a finite-dose model for skin pre-treated with terpenes and to evaluate the enhancing effect of some terpene formulations on alprazolam permeation.
METHODS: In vitro enhancement of alprazolam human skin permeation was investigated using a pretreatment with different terpene solutions. Vertical diffusion, Franz-type cells were used. Intrinsic drug permeation was also investigated. Transdermal permeation parameters were estimated from the permeation tabulates using different theoretical approaches for their calculation. Two groups of permeation parameters were calculated: modelistic (diffusion of a finite-dose of drug model) and parameters nondependent of a diffusional model.
RESULTS: In control experiments, all approaches of data treatment satisfactorily described the experimental permeation profiles. When skin pre-treatment was investigated, the fitting of a mathematical sigmoid function was much better than the diffusional approach. Pre-treatment of the skin with Limonene dissolved in ethanol / propylene glycol and Menthol dissolved in propylene glycol increased 15 and 10 times respectively the permeation parameters of alprazolam.
CONCLUSIONS: Using enhancers that are rapidly cleared from the skin, skin permeability does not remain constant during the permeation experiment and therefore it is not possible to calculate parameters that are usually true coefficients or definite values. In this case, non-modelistic parameters can be used to estimate an enhancing effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771235     DOI: 10.1007/s11095-004-9014-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Analysis of drug penetration through skin considering donor concentration decrease.

Authors:  M Hashida; H Okamoto; H Sezaki
Journal:  J Pharmacobiodyn       Date:  1988-09

2.  Effect of pretreatment of skin with cyclic monoterpenes on permeation of diclofenac in hairless rat.

Authors:  Y Obata; K Takayama; Y Maitani; Y Machida; T Nagai
Journal:  Biol Pharm Bull       Date:  1993-03       Impact factor: 2.233

3.  Physicochemical interpretation of the pharmacokinetics of percutaneous absorption.

Authors:  R H Guy; J Hadgraft
Journal:  J Pharmacokinet Biopharm       Date:  1983-04

4.  Influence of drug lipophilicity on terpenes as transdermal penetration enhancers.

Authors:  D A Godwin; B B Michniak
Journal:  Drug Dev Ind Pharm       Date:  1999-08       Impact factor: 3.225

5.  Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement.

Authors:  A C Williams; B W Barry
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

6.  Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharm Sci       Date:  2004-02       Impact factor: 3.534

7.  Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro. II: Drug, vehicle, and enhancer penetration kinetics.

Authors:  M Hori; H I Maibach; R H Guy
Journal:  J Pharm Sci       Date:  1992-04       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.